Skip to main content
. Author manuscript; available in PMC: 2018 Feb 1.
Published in final edited form as: Bioorg Med Chem. 2016 Dec 9;25(3):1004–1013. doi: 10.1016/j.bmc.2016.12.014

Figure 2.

Figure 2

Effect of 8 on echocardiographic parameters in LmnaH222P/H222P mice. (A) Representative transthoracic M-mode echocardiographic tracings from LmnaH222P/H222P mice treated with placebo or 8 at 3 mg/kg/day or 6 mg/kg/day. Left ventricular end systolic diameter (LVESD), left ventricular end diastolic diameter (LVEDD) are indicated. (B) Bar graphs show means and standard errors of means for left ventricular end systolic diameter (LVESD), left ventricular end diastolic diameter (LVEDD) and left ventricular fractional shortening (FS) in LmnaH222P/H222P mice treated with placebo (n = 22), 8 3 mg/kg/day (n = 19) or 8 6 mg/kg/day (n = 16). *P<0.05 compared to placebo.